Cargando…
Human urinary kallindinogenase therapy for acute ischemic stroke according to Chinese ischemic stroke subclassification: Clinical efficacy and risk factors
INTRODUCTION: To evaluate effectiveness of human urinary kallindinogenase (HUK) in patients with acute ischemic stroke (AIS) according to Chinese ischemic stroke subclassification (CISS) and analyzed risk factors of clinical efficacy. METHODS: In this retrospective study, 134 patients received conve...
Autores principales: | Chen, Si‐Qia, Mao, Dong‐Yang, Wei, Dun‐Can, He, Wen‐Zhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6955840/ https://www.ncbi.nlm.nih.gov/pubmed/31793238 http://dx.doi.org/10.1002/brb3.1461 |
Ejemplares similares
-
Chinese Ischemic Stroke Subclassification
por: Gao, S., et al.
Publicado: (2011) -
Comparison of the Chinese ischemic stroke subclassification and Trial of Org 10172 in acute stroke treatment systems in minor stroke
por: Tan, Sha, et al.
Publicado: (2016) -
Combination therapy with beraprost sodium and aspirin for acute ischemic stroke: a single-center retrospective study
por: Cai, De, et al.
Publicado: (2019) -
Efficacy and safety of human urinary kallidinogenase for acute ischemic stroke: a meta-analysis
por: Huang, Yuanxiang, et al.
Publicado: (2020) -
Acute Ischemic Stroke
por: Marfeo, Anthony
Publicado: (2009)